➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Medtronic
McKinsey
Dow

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Patent: 5,354,654

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,354,654
Title: Lyophilized ligand-receptor complexes for assays and sensors
Abstract:A dry reagent prepared by lyophilizing a labelled ligand-immobilized receptor complex or a labelled receptor-immobilized ligand complex is, on rehydration, useful for detecting analytes in samples in a variety of displacement assays.
Inventor(s): Ligler; Frances S. (Potomac, MD), Whelan; James P. (Potomac, MD)
Assignee: The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA)
Application Number:08/092,518
Patent Claims:see list of patent claims

Details for Patent 5,354,654

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ⤷  Try it Free The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) 2039-02-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ⤷  Try it Free The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) 2039-02-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ⤷  Try it Free The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) 2039-02-26 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ⤷  Try it Free The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) 2039-02-26 RX Orphan search
Fresenius Kabi Usa CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 004 1973-03-05 ⤷  Try it Free The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Merck
Boehringer Ingelheim
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.